Page last updated: 2024-12-09

thioacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Thioacetamide: A crystalline compound used as a laboratory reagent in place of HYDROGEN SULFIDE. It is a potent hepatocarcinogen. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

thioacetamide : A thiocarboxamide consiting of acetamide having the oxygen replaced by sulfur. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2723949
CHEMBL ID38737
CHEBI ID32497
MeSH IDM0021344

Synonyms (75)

Synonym
TAA ,
nsc2120
usaf ek-1719
acetamide, thio-
thiacetamide
nsc-2120
ethanethioamide
62-55-5
acetothioamide
acetimidic acid, thio-
thioacetamide
wln: zy1&us
usaf cb-21
CHEBI:32497 ,
methylthioamide
acetic acid thioamide
thioacetimidic acid
thioactamide
acetic acid, thiono-, amide
rcra waste no. u218
ai3-17220
nsc 2120
einecs 200-541-4
acetamide, thio- (van)
rcra waste number u218
hsdb 1318
ccris 584
thioacetamide, acs reagent, >=99.0%
thiacetamid
thioacetamide, reagent grade, 98%
inchi=1/c2h5ns/c1-2(3)4/h1h3,(h2,3,4)
yukqrdcynovpgj-uhfffaoysa-
CHEMBL38737
BMSE000781
T0187
AKOS000119931
A833844
C19302
NCGC00257539-01
dtxcid901340
tox21_301295
cas-62-55-5
dtxsid9021340 ,
ethanimidothioic acid
c2h5ns
unii-075t165x8m
075t165x8m ,
ec 200-541-4
BP-10926
FT-0631278
thioacetamide [iarc]
thioacetamide [hsdb]
thioacetamide [mi]
thioacetoamide
thioacteamide
ch3csnh2
STR00411
mfcd00008070
J-520440
F0001-1649
thioacetamide, acs reagent
thioacetamide, acs reagent, for the precipitation (of heavy metals), >=99.0%
thioacetamide, p.a., acs reagent, 99%
thioacetamide, vetec(tm) reagent grade, 98%
CS-W018499
Q416253
ethanethioamide;acetothioamide
BCP30336
STL199139
D70870
ethanethioamide; acetothioamide; thiacetamide
HY-Y0698
thiocetamide solution
EN300-19496
Z104474020

Research Excerpts

Overview

Thioacetamide (TAA) is a well-known hepatotoxicant and could be a liver carcinogen in humans. Long term exposure could induce liver fibrosis and cirrhosis.

ExcerptReferenceRelevance
"Thioacetamide (TAA) is a common organic compound with significant hepatotoxicity."( Oridonin Attenuates Thioacetamide-Induced Osteoclastogenesis Through MAPK/NF-κB Pathway and Thioacetamide-Inhibited Osteoblastogenesis Through BMP-2/RUNX2 Pathway.
Chen, J; Jin, X; Luo, F; Xu, B; Xu, J; Yang, F, 2023
)
1.96
"Thioacetamide (TAA) is a well-known hepatotoxic substance, so it is important to determine its presence and content in food and environmental samples. "( Electrochemiluminescence of Ru(bpy)
Bushira, FA; Jin, Y; Kitte, SA; Li, H, 2021
)
2.06
"Thioacetamide (TAA) is a well-known hepatotoxicant and could be a liver carcinogen in humans."( Mechanistic roles of microRNAs in hepatocarcinogenesis: A study of thioacetamide with multiple doses and time-points of rats.
Bisgin, H; Castro, C; Chen, T; Dweep, H; Gong, B; Gong, P; Hong, H; Liu, Z; Morikawa, Y; Shi, T; Tong, W; Uehara, T; Wang, Y; Yan, J; Zou, W, 2017
)
1.41
"Thioacetamide (TAA) is a hepatotoxin that rapidly triggers the necrotic process and oxidative stress in the liver. "( Antioxidant protection by β-selenoamines against thioacetamide-induced oxidative stress and hepatotoxicity in mice.
Amaral, GP; Courtes, AA; da Rosa, PC; da Silva, TC; Dornelles, L; Gonçalves, DF; Hartmann, DD; Leite, MTB; Soares, FAA; Souza, MB; Stefanello, ST, 2017
)
2.15
"Thioacetamide (TAA) is a well-known hepatotoxin that induces liver fibrosis."( Protective effect of alpha-mangostin on thioacetamide-induced liver fibrosis in rats as revealed by morpho-functional analysis.
Nilbu-Nga, C; Pongmayteegul, S; Poonkhum, R; Pradidarcheep, W; Rodniem, S; Tiyao, V, 2019
)
1.5
"Thioacetamide (TAA) is a well-known toxicant and its long term exposure could induce liver fibrosis and cirrhosis. "( Toxic effects of chronic low-dose exposure of thioacetamide on rats based on NMR metabolic profiling.
Kong, LY; Li, MH; Wang, JS; Wang, PR; Wei, DD; Yang, MH, 2014
)
2.1
"Thioacetamide (TA) is a potent hepatotoxicant known to affect liver metabolism, inhibit mRNA transport and induce immune suppression. "( Expression analysis of early response-related genes in rat liver epithelial cells exposed to thioacetamide in vitro.
Hwang, SY; Kang, KS; Kim, JK; Kim, SJ; Lee, YS; Oh, MJ; Park, JS; Paul, S; Yeom, HJ, 2009
)
2.02
"Thioacetamide (TAA) is a hepatotoxin frequently used for experimental purposes which produces centrilobular necrosis after a single dose administration. "( The toxic effect of thioacetamide on rat liver in vitro.
Cervinková, Z; Endlicher, R; Kučera, O; Lotková, H; Roušar, T; Staňková, P, 2010
)
2.13
"Thioacetamide (TA) is a commonly used drug that can trigger acute hepatic failure (AHF) through generation of oxidative stress. "( The role of vitamin D3 upregulated protein 1 in thioacetamide-induced mouse hepatotoxicity.
Choi, IP; Han, JT; Kim, DY; Kim, HC; Kwon, HJ; Lee, SB; Lim, JH; Nam, KH; Won, YS; Yoon, WK, 2010
)
2.06
"Thioacetamide (TAA) is a potent hepatotoxicant and has been widely used to develop experimental liver fibrosis/cirrhosis models. "( Thioacetamide intoxication triggers transcriptional up-regulation but enzyme inactivation of UDP-glucuronosyltransferases.
Gong, P; Hao, H; Jiang, S; Sun, S; Wang, G; Xie, Y; Zhang, L; Zhou, X, 2011
)
3.25
"Thioacetamide (TA) is a well-known hepatotoxin in rats. "( Covalent modification of lipids and proteins in rat hepatocytes and in vitro by thioacetamide metabolites.
Galeva, NA; Hajovsky, H; Hanzlik, RP; Koen, YM; Sarma, D; Staudinger, JL; Williams, TD, 2012
)
2.05
"Thioacetamide (TAA) is a potent hepatotoxin that causes centrilobulal necrosis and nephrotoxic damage following acute administration. "( Effect of coriander on thioacetamide-induced hepatotoxicity in rats.
Ali, EM; El-Said, KS; Moselhey, SS; Moustafa, AH; Tousson, E, 2014
)
2.16
"Thioacetamide is a hepatotoxic and hepatocarcinogenic compound that affects liver metabolism, inhibits mRNA transport and induces enlargement of the nucleolus. "( Differentially expressed genes in the liver of thioacetamide treated rats.
Raw, I; Spira, B, 2003
)
2.02
"Thioacetamide (TA) is a weak hepatocarcinogen causing several types of liver damage in a dose dependent manner and ultimately producing malignant transformation."( Expression of G1 cell cycle regulators in rat liver upon repeated exposure to thioacetamide.
Han, SY; Jeong, JS; Kim, KT, 2007
)
1.29
"Thioacetamide proved to be a potent necrogenic agent when a single dose of 6.6 mmol/kg was administered intraperitoneally to rats. "( Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide.
Alvarez, A; Boscá, L; Cascales, M; Díez-Fernández, C; Fernández-Simón, L, 1993
)
1.94
"Thioacetamide (TA) is a well-known hepatotoxicant. "( Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats.
Fultz, CD; Mangipudy, RS; Mehendale, HM; Witzmann, FA, 1996
)
1.95
"Thioacetamide is a weak hepatocarcinogen. "( Lyso-phosphatidylcholine is implicated in thioacetamide-induced liver necrosis.
Aylagas, H; Mirò-Obradors, MJ; Osada, J; Palacios-Alaiz, E, 1988
)
1.98

Effects

Thioacetamide (TA) has long been known as a hepatotoxicant. Bioactivation requires S-oxidation to thioacetamide S-oxide (TASO) and then to the very reactive S,S-dioxide (TasO2) TAA has been used extensively in the development of animal models of acute liver injury.

ExcerptReferenceRelevance
"Thioacetamide (TA) has long been known as a hepatotoxicant whose bioactivation requires S-oxidation to thioacetamide S-oxide (TASO) and then to the very reactive S,S-dioxide (TASO2). "( Protein targets of thioacetamide metabolites in rat hepatocytes.
Galeva, NA; Hajovsky, H; Hanzlik, RP; Koen, YM; Sarma, D; Staudinger, JL; Williams, TD, 2013
)
2.16
"Thioacetamide (TAA) has been used in development of animal models of acute hepatic encephalopathy (AHE). "( Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study.
El Awdan, SA; Hegazy, GA; Mustafa, HN, 2013
)
2.11
"Thioacetamide (TAA) has been used to develop a rodent model for hepatocarcinogenesis. "( Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
Abe, H; Kimura, M; Morita, R; Ogawa, T; Shibutani, M; Tanaka, T; Wang, L; Yoshida, T, 2014
)
2.05
"Thioacetamide (TAA) has served as an excellent sulfur source to react with cadmium stearate to controllably produce highly luminescent and monodisperse CdS nanocrystals through the hot-injection method in dodecylamine solvent. "( Hot-injection synthesis of highly luminescent and monodisperse CdS nanocrystals using thioacetamide and cadmium source with proper reactivity.
Guo, S; Liang, H; Liang, ZH; Shen, XC; Zhang, LJ, 2010
)
2.03
"Thioacetamide has been known to cause immune suppression. "( Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression.
Ha, H; Han, MY; Han, SS; Jeong, TC; Kim, EJ; Koh, WS; Lee, JW; Lee, M; Shin, KD, 2003
)
2.01
"Thioacetamide (TAA) has been used in studying liver fibrosis and cirrhosis, however, the mechanisms of TAA-induced apoptosis in liver are still unclear. "( Involvement of P53 and Bax/Bad triggering apoptosis in thioacetamide-induced hepatic epithelial cells.
Chen, LH; Hsu, CY; Weng, CF, 2006
)
2.02
"Thioacetamide (TAA) has been used extensively in the development of animal models of acute liver injury. "( Single dose intravenous thioacetamide administration as a model of acute liver damage in rats.
Chen, TM; Chiou, TW; Hsu, BG; Lee, RP; Subeq, YM, 2008
)
2.1

Actions

ExcerptReferenceRelevance
"Thioacetamide caused an increase in DNA migration in the stomach of rats treated at 19, 38, and 75 mg/kg/day, but not in the liver, despite evidence of marked hepatotoxicity following histopathology assessments."( Investigation of sodium arsenite, thioacetamide, and diethanolamine in the alkaline comet assay: Part of the JaCVAM comet validation exercise.
Beevers, C; Henderson, D; Lillford, L, 2015
)
1.42

Treatment

Thioacetamide treatment results in striking increases in the nuclear ribonucleoproteins of the liver cell. Long-term administration of extract aggravated the inflammatory and fibrotic and glutathione depleting responses without affecting the extent of lipid peroxidation.

ExcerptReferenceRelevance
"Thioacetamide treatment resulted in hepatic dysfunction manifested by increased serum levels of bilirubin, gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST)."( A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases.
Alharbi, FM; Alhusaini, AM; Alshanwani, AR; Arafah, MM; Badr, AM; Faddah, LM; Fayed, A; Hagar, H; Shaheen, S; Sharma, AK, 2022
)
1.69
"Thioacetamide-treated mice had tissue collected at up to 3 days following daily injections."( Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice.
DeMorrow, S; Frampton, G; Grant, S; Jaeger, V; Kain, J; McMillin, M; Petrescu, AD; Williams, E, 2018
)
1.51
"In thioacetamide-treated rats, pretreatment with the SSRIs drugs fluoxetine and sertraline is associated with decreased lipid peroxidation in brain; liver peroxidation, however, is increased. "( The effect of antidepressant drugs on thioacetamide-induced oxidative stress.
Abdel Salam, OM; Farrag, AR; Mohammed, NA; Sleem, AA, 2013
)
1.28
"Thioacetamide treatment enhanced hepatic expression of CD133 and phosphorylated signal transducer and activator of transcription 3 (STAT3), which was prevented by treatment with the antioxidant butylated hydroxyanisole."( Cold-inducible RNA-binding protein promotes the development of liver cancer.
Arizumi, T; Fujita, J; Hagiwara, S; Kudo, M; Nishida, N; Sakurai, T; Ueshima, K; Watanabe, T; Yada, N, 2015
)
1.14
"thioacetamide-treated group (TAA; 900 mg/kg); 3."( Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats.
Djuric, D; Hrnčić, D; Jevtić, G; Maksić, N; Mladenović, D; Petronijević, N; Radosavljević, T; Rašić-Marković, A; Stanojlović, O; Stojković, T; Velimirović, M, 2015
)
1.35
"Thioacetamide treatment induced two phases of liver fibrosis."( Spatiotemporal Characterization of the Cellular and Molecular Contributors to Liver Fibrosis in a Murine Hepatotoxic-Injury Model.
Alexander, KA; Beattie, L; Boyle, GM; Clouston, AD; Gadd, VL; Hill, GR; Irvine, KM; Le Texier, L; Lineburg, KE; MacDonald, KP; Martinez, M; Melino, M; Miller, GC; Powell, EE; Teal, B, 2016
)
1.16
"Thioacetamide (TAA)-treated rats were used in this study."( Efficacy of urine bile acid as a non-invasive indicator of liver damage in rats.
Kawai, H; Kawashima, Y; Kudo, N; Mitsumoto, A, 2009
)
1.07
"Thioacetamide treatment caused significant increases in liver enzymes, ATX activities, and liver hydroxyproline, but a significant decrease in plasma's TAC."( Effect of histidine on autotaxin activity in experimentally induced liver fibrosis.
El-Batch, M; Ibrahim, W; Said, S,
)
0.85
"thioacetamide-treated groups, TAA300 (300 mg/kg), TAA600 (600 mg/kg) and TAA900 (900 mg/kg)."( Different sensitivity of various brain structures to thioacetamide-induced lipid peroxidation.
Colović, M; Hrncić, D; Krstić, D; Macut, D; Mladenović, D; Radosavljević, T; Rasić-Marković, A; Stanojlović, O, 2012
)
1.35
"Thioacetamide treatment results in striking increases in the nuclear ribonucleoproteins of the liver cell without affecting the mitotic rate during regeneration (14)."( Effect of thioacetamide on rat liver regeneration. II. Nuclear RNA in mitosis.
KLEINFELD, RG; VON HAAM, E, 1959
)
1.36
"In thioacetamide-treated rats, long-term administration of extract aggravated the inflammatory and fibrotic and glutathione depleting responses without affecting the extent of lipid peroxidation."( The effects of aqueous extracts prepared from the leaves of Pistacia lentiscus in experimental liver disease.
Azaizeh, H; Bomzon, A; Cogan, U; Ljubuncic, P; Song, H, 2005
)
0.84
"In thioacetamide-treated rat liver, the reactive oxygen species content is high and the reductase is fully activated with no modifications in its K(M) and its short term regulatory enzymes. "( Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content.
Bassi, AM; Martini, C; Nanni, G; Pallottini, V; Romano, P; Trentalance, A, 2006
)
1.23
"In thioacetamide treated group, many fold increase in the activity level of serum marker enzymes suggesting FHF was observed that could be brought down significantly in rats receiving boron."( Boron ameliorates fulminant hepatic failure by counteracting the changes associated with the oxidative stress.
Ali, S; Pawa, S, 2006
)
0.85
"Thioacetamide treatment also enhanced putrescine excretion, which again was concomitant with an increased excretion of N1-acetylspermidine."( Acetylation of spermidine in polyamine catabolism.
Bolkenius, FN; Knödgen, B; Seiler, N, 1980
)
0.98
"Thioacetamide-treated rats showed a drop in total plasma fatty acids, higher percentages of palmitic acid in all lipid fractions, and lower levels of stearic acid in erythrocyte lipids and liver microsomal phospholipids."( Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats.
Fontana, L; Gil, A; Moreira, E; Periago, JL; Sanchéz De Medina, F, 1995
)
1.22
"Thioacetamide-treated rats were more sensitive to flunitrazepam than controls. "( Hepatic encephalopathy in rats with thioacetamide-induced acute liver failure is not mediated by endogenous benzodiazepines.
Ferenci, P; Herneth, A; Püspök, A; Steindl, P, 1993
)
2
"Thioacetamide treatment produced a severe alteration in the plasma fatty acid profile with significant decreases of these, which mimicked changes described in human cirrhosis."( Influence of administration of long-chain polyunsaturated fatty acids on process of histological recovery in liver cirrhosis produced by oral intake of thioacetamide.
Fernández, I; Fontana, L; Gil, A; Moreira, E; Rios, A; Torres, I, 1996
)
1.21
"Thioacetamide-treated rats showed diminished mucosa weight; protein, DNA, and RNA content; and leucine aminopeptidase activity as compared to controls in both jejunum and ileum."( Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine.
Fernández, MI; Gil, A; Ortega, MA; Rios, A; Sánchez-Pozo, A; Torres, MI, 1997
)
1.35
"Thioacetamide treatment of Chang cells increased cell GSH and GS expression by 50%, but had minimal influence on GCS subunits."( Inducers of gamma-glutamylcysteine synthetase and their effects on glutathione synthetase expression.
Chen, C; Huang, ZA; Lu, SC; Yang, H; Zeng, Z, 2000
)
1.03
"Thioacetamide treatment was associated with an 8.7-fold increase in plasma immunoreactive methionine enkephalin levels (P less than or equal to 0.005) 24 h after treatment."( Methionine enkephalin accumulates in plasma but not in brain or cerebrospinal fluid of rats with acute toxic hepatitis.
Heyes, MP; Jones, EA; Swain, MG; Vergalla, J, 1992
)
1
"Thioacetamide treatment brought about significant (P less than 0.05) stimulation of DNA synthesis in the liver and kidney thus confirming, but extending an earlier finding."( Effect of thioacetamide on the incorporation of [3H]-thymidine into DNA of 13 tissues and on the mitotic index of the corneal epithelium of BD2F1 in male mice while taking into consideration circadian variation.
Scheving, LA; Scheving, LE; Tsai, TH, 1986
)
1.39
"Treatment with thioacetamide significantly elevated the level of serum glutamic-oxaloacetic transaminase (1.75-fold), alkaline phosphatase (4.07-fold), and total bilirubin (2.29-fold) as compared to the control."( Amelioration of hepatic function, oxidative stress, and histopathologic damages by Cassia fistula L. fraction in thioacetamide-induced liver toxicity.
Kaur, S; Sharma, D; Singh, AP, 2019
)
1.06
"Untreated and thioacetamide-treated mouse AML12 hepatocytes were incubated for 24 hours with the control medium, LPS (0.5 ng/mL), CM, and LPS-CM and then cell viabilities were compared."( Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome.
Jeong, HJ; Kim, SJ; Lee, SC; Lee, SK, 2015
)
0.76
"Treatment with thioacetamide (TAA) at low-dose concentrations caused minimal hepatic inflammation in both wild-type (WT) and AID transgenic (Tg) mice."( Hepatic inflammation facilitates transcription-associated mutagenesis via AID activity and enhances liver tumorigenesis.
Chiba, T; Eso, Y; Ikeda, A; Marusawa, H; Matsumoto, T; Matsumoto, Y; Nishijima, N; Shimizu, T, 2015
)
0.76
"Treatment with thioacetamide (150 mg/kg) was used to enhance polyamine metabolism in rat liver. "( Acetylation of spermidine in polyamine catabolism.
Bolkenius, FN; Knödgen, B; Seiler, N, 1980
)
0.61
"Pretreatment with thioacetamide in vivo resulted in enhanced bile fluid formation in subsequently isolated and perfused livers. "( Bile ductular proliferation and altered leukotriene elimination in thioacetamide-induced fibrosis of rat liver.
Dietze, E; Enderle, GJ; Krell, H; Löw, O; Müller, D, 1996
)
0.86
"Rats treated with thioacetamide undergo hepatocellular proliferation reminscent of liver regeneration following partial hepatectomy. "( Stimulation of hepatocellular proliferation by a serum factor from thioacetamide-treated rats.
Boyer, JL; Morley, CG, 1977
)
0.83
"Treatment with thioacetamide increased the rate of synthesis of di- and triacylglycerols from glycerol phosphate by liver homogenates, the activity of phosphatidate phosphohydrolase and the incorporation of [3H]glycerol into liver triacylglycerol in vivo."( Effects of an antitumoural rhodium complex on thioacetamide-induced liver tumor in rats. Changes in the activities of ornithine decarboxylase, tyrosine aminotransferase and of enzymes involved in fatty acid and glycerolipid synthesis.
Brindley, DN; Cascales, C; Cascales, M; Hopewell, R; Martin-Sanz, P; Pittner, RA, 1986
)
0.87

Toxicity

Study investigated susceptibility of the liver to the toxic actions of thioacetamide. Evidences suggest that ROS is involved in nephrotoxicity through frequent exposure to industrial toxic agents.

ExcerptReferenceRelevance
" This indicates less conjugation of the toxic metabolites of paracetamol and bromobenzene to liver glutathione (G-SH) in the presence of DMSO."( Antidotal effects of dimethyl sulphoxide against paracetamol-, bromobenzene-, and thioacetamide-induced hepatotoxicity.
Siegers, CP, 1978
)
0.48
" The overall results show the necessity of TASO bioactivation by mixed-function monooxygenases for the toxic action to be apparent; at the same time, the findings suggest FADM as the system mainly involved in TASO metabolism."( Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide.
Chieli, E; Malvaldi, G, 1984
)
0.5
" The objective of the present study was to further scrutinize this concept in an experimental protocol in which we hypothesized that a selective ablation of the tissue repair response should lead to lethality from the nonlethal, moderately toxic doses of 150 and 300 mg/kg TA."( Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.
Mangipudy, RS; Mehendale, HM; Rao, PS, 1996
)
0.55
" our present results suggest that beta-ionone may be a useful model inducer of P450 enzyme(s) in studying toxic mechanism of certain chemicals which require metabolic activation by P450s in mice."( Pretreatment of male BALB/c mice with beta-ionone potentiates thioacetamide-induced hepatotoxicity.
Gu, HK; Ha, CS; Jeong, TC; Kim, HC; Park, JI; Roh, JK; Yun, HI, 1999
)
0.54
" In this study, the toxic effect of thioacetamide on the spleen was investigated at 0, 4, 8 and 12 weeks post-treatment durations."( Thioacetamide toxicity and the spleen: histological and biochemical analysis.
al-Bader, A; al-Sayer, H; Asfar, S; Dashti, HM; Khoursheed, M; Mathew, TC, 2000
)
2.02
"In order to investigate gene expression changes associated with cytotoxicity, we used cDNA arrays to monitor the expression of over 5,000 genes in response to toxic stress in the HepG2 liver cell line."( Gene expression changes associated with cytotoxicity identified using cDNA arrays.
Gore, MA; Morshedi, MM; Reidhaar-Olson, JF, 2000
)
0.31
" Histopathology confirmed the toxic effects of CdCl2 on liver and kidney; doxorubicin on kidney, liver, and intestine; and thioacetamide on the liver."( In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice.
Ang, A; Contag, PR; Jekic-McMullen, D; Malstrom, SE; Purchio, AF; Reeves, R; Sambucetti, L; West, DB, 2004
)
0.53
" From the eigenvector loadings of the PCA, those regions of the 1H NMR spectra, and hence the combinations of endogenous metabolites marking the main phase of the toxic episode, were identified."( Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity.
Farrant, RD; Holmes, E; Nicholson, JK; Waterfield, CJ; Waters, NJ, 2005
)
0.57
"In the field of gene expression analysis, DNA microarray technology has a major impact on many different areas including toxicogenomics, such as in predicting the adverse effects of new drug candidates and improving the process of risk assessment and safety evaluation."( Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats.
Kato, H; Katoh, M; Minami, K; Nakajima, M; Narahara, M; Saito, T; Sugiyama, H; Tomita, H; Yokoi, T, 2005
)
0.33
" The major gene expression profile obtained by quality-threshold (QT) clustering analysis showed the same maximal toxic time as that estimated by the serum biochemical markers."( Simultaneous measurement of gene expression for hepatotoxicity in thioacetamide-administered rats by DNA microarrays.
Katoh, M; Maniratanachote, R; Minami, K; Nakajima, M; Yokoi, T, 2006
)
0.57
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
" This study investigated the susceptibility of the liver to the toxic actions of thioacetamide (TA) in a rat model of IR, induced by feeding the rats a high-fructose diet (60 g/100 g) for 30 days."( Insulin resistance induced by a high-fructose diet potentiates thioacetamide hepatotoxicity.
Anuradha, CV; Pooranaperundevi, M; Sumiyabanu, MS; Sundarapandiyan, R; Viswanathan, P, 2010
)
0.83
" Thus, the toxic effects of TA are potentiated due to compromised liver function in the setting of IR."( Insulin resistance induced by a high-fructose diet potentiates thioacetamide hepatotoxicity.
Anuradha, CV; Pooranaperundevi, M; Sumiyabanu, MS; Sundarapandiyan, R; Viswanathan, P, 2010
)
0.6
" Oxidation of the NADH-dependent substrates of respiratory Complex I is significantly more sensitive to the toxic action of TAA than oxidation of the flavoprotein-dependent substrate of Complex II."( The toxic effect of thioacetamide on rat liver in vitro.
Cervinková, Z; Endlicher, R; Kučera, O; Lotková, H; Roušar, T; Staňková, P, 2010
)
0.68
" There is only little evidence about altered sensitivity of steatotic liver to acute toxic injury."( Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?
Cervinková, Z; Kučera, O; Lotková, H; Mezera, V; Podhola, M; Roušar, T; Staňková, P, 2011
)
0.59
" Treatment with coriander leaves and seeds helps in improving the adverse effect of TAA-induced hepatotoxicity; also the histological study confirms this finding."( Effect of coriander on thioacetamide-induced hepatotoxicity in rats.
Ali, EM; El-Said, KS; Moselhey, SS; Moustafa, AH; Tousson, E, 2014
)
0.71
"Recent work has demonstrated the importance of post-transcriptional gene regulation in toxic responses."( Decreased translation of Dio3 mRNA is associated with drug-induced hepatotoxicity.
Darras, VM; Dudek, KM; Gant, TW; Marczylo, EL; Suter, L, 2013
)
0.39
" Evidences suggest that ROS is involved in nephrotoxicity through frequent exposure to industrial toxic agents such as thioacetamide (TAA)."( Effect of oral administration of ethanolic extract of Vitex negundo on thioacetamide-induced nephrotoxicity in rats.
Abdulla, MA; Kadir, FA; Kassim, NM; Yehye, WA, 2013
)
0.83
" Treatment of TAA intoxicated rats (G4) with MOLE ameliorated the toxic effects of TAA on hepatic tissue structure and function."( Protective effect of Moringa oleifera leaves ethanolic extract against thioacetamide-induced hepatotoxicity in rats via modulation of cellular antioxidant, apoptotic and inflammatory markers.
El Sabagh, HS; El-Gansh, HAI; Eldaim, MAA; Mohamed, MAE; Morsi, AH; Mousa, AA, 2019
)
0.75
" The toxic effects of TAA on the femurs of New Zealand white rabbits and the underlying toxicity mechanism were investigated in this study."( Toxic effects of thioacetamide-induced femoral damage in New Zealand white rabbits by activating the p38/ERK signaling pathway.
Cheng, L; Jin, X; Li, Y; Xu, B; Xu, J; Yao, Y; Ying, H, 2022
)
1.06
"Our study aimed to investigate the role of betaine in the modulation of MIF-mediated oxidative stress, inflammation, and fibrogenesis during toxic kidney damage induced by thioacetamide (TAA)."( Betaine Modulating MIF-Mediated Oxidative Stress, Inflammation and Fibrogenesis in Thioacetamide-Induced Nephrotoxicity.
Filipović, J; Jorgačević, B; Radosavljević, T; Samardžić, J; Stanković, S; Vučević, D, 2022
)
1.14

Pharmacokinetics

ExcerptReferenceRelevance
" Statistical comparisons indicated that there were no significant differences in the pharmacokinetic parameters estimated in the two groups of animals."( Effect of experimentally-induced hepatic cirrhosis on the pharmacokinetics of orally administered praziquantel in the rat.
Kokwaro, GO; Taylor, G,
)
0.13

Bioavailability

ExcerptReferenceRelevance
" On the other hand, selenium supplementation to selenium-deficient mice always more efficiently increased hepatic glutathione peroxidase activity and selenium content compared with those treated with thioacetamide, indicating that thioacetamide impairs the liver bioavailability of selenium."( Thioacetamide-induced cirrhosis in selenium-adequate mice displays rapid and persistent abnormity of hepatic selenoenzymes which are mute to selenium supplementation.
Wang, H; Yu, H; Zhang, J, 2007
)
1.97
"Methacetin is well absorbed and exclusively metabolized in the liver."( Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
Aeed, H; Avni, Y; Ilan, Y; Shahmurov, M; Shalev, T; Shirin, H; Sorin, V; Stavinski, S, 2008
)
0.35
" The encapsulation of curcumin inside the apoferritin cavity significantly increases its stability and bioavailability while maintaining its therapeutic anti-inflammatory properties."( Curcumin/Gd loaded apoferritin: a novel "theranostic" agent to prevent hepatocellular damage in toxic induced acute hepatitis.
Aime, S; Burghelea, D; Crich, SG; Cutrin, JC; Dastrù, W, 2013
)
0.39
" Its poor oral bioavailability leads to frequent administration causing severe adverse effects."( Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator.
Abd El-Halim, SM; Abdelbary, GA; Amin, MM; Ibrahim, AB; Shamsel-Din, HA; Zakaria, MY, 2020
)
0.56
" Therefore, this study was designed to accelerate the absorption of these phyto-constituents and hence increase their bioavailability by incorporating silver (Ag-NPs) and zinc oxide nanoparticles (ZnO-NPs) due to their impressive properties."( Assessment of the Biological Activities of Egyptian Purslane (Portulaca oleracea) Extract after Incorporating Metal Nanoparticles, in Vitro and in Vivo Study.
Aboulthana, WM; Ahmed, KA; Hasan, EA; Omar, NI; Youssef, AM, 2022
)
0.72
"This study aimed to investigate the possible usefulness of morin flavonoid in comparison to silymarin as a hepatic/neuronal-supportive agent with similar effects and higher bioavailability in a rat model of hepatic encephalopathy (HE)."( Molecular mechanisms involved in the effects of morin in experimental hepatic encephalopathy.
Attia, AS; El-Ghazaly, MA; Rashed, ER; Shafey, GM; Zaki, HF, 2022
)
0.72

Dosage Studied

Dose-response relationships for trichloroethylene (TCE), allyl alcohol (AA), thioacetamide (TA), and chloroform alone or as mixtures were studied. High dosage of the diosmin-hesperidin mixture induces slight changes in the Cu, Zn, Mn and Fe content of the liver.

ExcerptRelevanceReference
" More severe liver damage by CCl4 or thioacetamide, which lowers hepatic cytochrome P-450, causes impairment of estrogen degradation: CCl4 dosage leads to a marked decrease in aromatic hydroxylation of estradiol."( Effects of hepatotoxic agents on hepatic microsomal metabolism of estrogens in the rat.
Bolt, HM; López del Pino, V, 1977
)
0.53
"The urinary excretion of taurine by rats after dosing with various hepatotoxins has been investigated by 1H NMR spectroscopy."( Hepatotoxin-induced hypertaurinuria: a proton NMR study.
Elcombe, C; Nicholson, JK; Sanins, SM; Timbrell, JA, 1990
)
0.28
" The consequences of liver damage for withdrawal times and dosage schedules are discussed."( The pharmacokinetic behaviour of chloramphenicol in liver-damaged mini-pigs.
Kroker, R, 1985
)
0.27
" Plasma arginine levels were significantly lowered 3 h after dosing thioacetamide and by 9 h were indistinguishable."( Early changes in thioacetamide-induced liver damage.
Trennery, PN; Waring, RH, 1983
)
0.84
" Quantitation of gene dosage by comparison of hybridization kinetics of fractionated cDNA and unique [3H]DNA with total rat cellular DNA indicates that there are not more than two copies of the albumin gene present in the rat genome."( Molecular basis for increased synthesis of albumin in rat liver after thioacetamide administration.
Chakrabarty, PK; Chattopadhyay, SK; Schneider, WC, 1982
)
0.5
"The purpose of the present study was to establish a dose-response relationship for thioacetamide (TA), where tissue regeneration as well as liver injury were two simultaneous but opposing responses."( Tissue repair response as a function of dose in thioacetamide hepatotoxicity.
Chanda, S; Mangipudy, RS; Mehendale, HM, 1995
)
0.77
" It is, however, obvious that both in rats and mice the severity of symptoms depends not only on dose and dosing schedule of TAA, but also on strain and body weight (age)."( Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.
Grauffel, C; Knödgen, B; Sarhan, S; Seiler, N, 1993
)
0.53
" Measuring tissue repair and injury as simultaneous biological responses to toxic agents might increase the usefulness of dose-response paradigms in risk assessment."( Injury and repair as opposing forces in risk assessment.
Mehendale, HM, 1995
)
0.29
" In a separate study using the dose-response paradigm, it was established that the rate and the extent of the tissue repair response following infliction of injury after acute exposure has a critical bearing on the ultimate outcome of toxicity (Mangipudy et al."( Temporal changes in tissue repair upon repeated exposure to thioacetamide.
Mangipudy, RS; Mehendale, HM, 1998
)
0.54
" Dose-response relationships for trichloroethylene (TCE), allyl alcohol (AA), thioacetamide (TA), and chloroform alone or as mixtures were studied."( Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology.
Clewell, H; Mehendale, HM; Mumtaz, MM; Ramaiah, SK; Soni, MG, 1999
)
0.53
" Continued administration of the drug at this dosage led to the development of further changes in the liver."( Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide.
Abul, H; Al-Bader, A; Al-Sayer, H; Dashti, HM; Mathew, TC; Singal, PK, 2000
)
0.54
"The content of dolichol, an isoprenoid present in all biological membranes, was determined in isolated sinusoidal liver cells after treatment of rats for 2 and 4 months with a low dosage of the hepatotoxin thioacetamide."( Dolichol content in isolated sinusoidal liver cells after in vivo chronic treatment with thioacetamide.
Bassi, AM; Canepa, C; Casu, A; Majorani, F; Maloberti, G; Nanni, G, 2002
)
0.72
" Rats were given daily subcutaneous injections of thioacetamide as a 1 per cent solution at a dosage of 5 mg."( Effect of thioacetamide on rat liver regeneration. II. Nuclear RNA in mitosis.
KLEINFELD, RG; VON HAAM, E, 1959
)
0.89
"Our aim was to study the distribution of dolichol, dolichol isoprenoids, and retinol in hepatocytes, Kupffer, sinusoidal endothelial and two subfractions of hepatic stellate cells, --Ito-1 and Ito-2--, after chronic treatment of rats for 2 and 4 months with a low dosage of thioacetamide associated with ethanol."( Association of thioacetamide and ethanol treatment: dolichol and retinol in isolated rat liver cells.
Bassi, AM; Canepa, C; Casu, A; Cottalasso, D; Maloberti, G; Nanni, G, 2004
)
0.85
" Male Han-Wistar rats were dosed with thioacetamide (150 mg/kg, n = 25), and urine, plasma, liver, and kidney samples were collected postdose for conventional NMR and magic angle spinning (MAS) NMR spectroscopy."( Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity.
Farrant, RD; Holmes, E; Nicholson, JK; Waterfield, CJ; Waters, NJ, 2005
)
0.84
" We assessed the impact of daily dosing on biochemical and morphological indices and the extent of oxidative stress in the livers of healthy and thioacetamide-treated rats."( The effects of aqueous extracts prepared from the leaves of Pistacia lentiscus in experimental liver disease.
Azaizeh, H; Bomzon, A; Cogan, U; Ljubuncic, P; Song, H, 2005
)
0.53
" The objective of this study was to examine whether increasing doses of TA lead to enzyme saturation, thereby resulting in lack of dose-response for injury: bioactivation of TA --> TASO --> TASO2 may follow zero-order kinetics."( Saturation toxicokinetics of thioacetamide: role in initiation of liver injury.
Chilakapati, J; Hill, RA; Korrapati, MC; Mehendale, HM; Shankar, K, 2005
)
0.62
" Hierarchical clustering analysis of all dosage groups revealed in 2 major clusters, distinguished by an early (6 and 12h) and a late (24, 36 and 48 h) phase."( Simultaneous measurement of gene expression for hepatotoxicity in thioacetamide-administered rats by DNA microarrays.
Katoh, M; Maniratanachote, R; Minami, K; Nakajima, M; Yokoi, T, 2006
)
0.57
" However, in the rats dosed with galactosamine hydrochloride, which showed highly variable amounts of liver damage at ca."( Hepatotoxin-induced hypertyrosinemia and its toxicological significance.
Charuel, C; Clayton, TA; Everett, JR; Hanton, G; Le Net, JL; Lindon, JC; Nicholson, JK; Provost, JP, 2007
)
0.34
" Previously, we have established that TA exhibits saturation toxicokinetics over a 12-fold dose range, which explains the lack of dose-response for bioactivation-based liver injury."( Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide.
Chilakapati, J; Hill, RA; Korrapati, MC; Latendresse, JR; Mehendale, HM; Warbritton, A, 2007
)
0.63
" On the basis of results it seems that high dosage of the diosmin-hesperidin mixture induces slight changes in the Cu, Zn, Mn and Fe content of the liver, however it may decrease the scavenger capacity and the activity of SOD when applied either alone or together with thioacetamide."( Effects of citrus flavonoids on redox homeostasis of toxin-injured liver in rat.
Blázovics, A; Fehér, E; Kurucz, T; Lugasi, A; Pallai, Z; Rapavi, E; Székely, E; Szentmihályi, K, 2006
)
0.51
" Depending on the intended indication and dosing regimen, PPL can delay or stop development of a compound in the drug discovery process."( Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.
Gehlhaar, D; Greene, N; Johnson, TO; Pelletier, DJ; Tilloy-Ellul, A,
)
0.13
" However, little is known about the possible reversing effects of hepatoprotective agents, the understanding of which is of great importance in guiding clinical dosage adjustment for patients with liver injury."( Cytochrome P450 dysregulations in thioacetamide-induced liver cirrhosis in rats and the counteracting effects of hepatoprotective agents.
Hao, H; Jiang, S; Kang, A; Wang, G; Wang, H; Xie, T; Xie, Y; Yao, X; Zhou, F, 2012
)
0.66
"Sorafenib, which is approved for treatment of HCC, has also shown promising antifibrotic activity, and therefore refinement of its dosing requirements and window of efficacy are important goals prior to antifibrotic clinical trials."( Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo.
Chou, H; Fiel, MI; Friedman, SL; Hong, F, 2013
)
0.39
" TAA administration for 8 weeks induced extensive hepatic fibrosis, whereupon 1D11 dosing was initiated and maintained for 8 additional weeks."( Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.
Arbeeny, C; Hempel, D; Ledbetter, S; Ling, H; Lonning, S; Roux, E; Smith, M; Tao, J; Zuk, A, 2013
)
0.6
"9%NaCl, injected intraperitoneally at a dosage of 200mg/Kg of body weight, twice a week for 12 weeks."( Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats.
Fatima, SN; Mahboob, T; Shahid, SM, 2013
)
0.39
" Also, because of the potential interactions of SB and co-administered medicines, it might be necessary to adjust the dosage in the clinical medication of liver disease."( Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulation.
Hao, HP; Wang, GJ; Wang, H; Wang, ZX; Xie, Y, 2013
)
0.39
" NaClO dosing had no adverse impact on the formation of currently regulated disinfection by-product compounds (THMs and HAAs)."( Pre-treatment for ultrafiltration: effect of pre-chlorination on membrane fouling.
Graham, N; Qu, J; Xu, L; Yu, W, 2014
)
0.4
" The test substance, TAA, was administered orally to 6-week-old male Crl:CD (SD) rats once daily for 14 or 28 days at a dosage of 5, 10 or 20mg/kg/day."( Evaluation of in vivo genotoxicity by thioacetamide in a 28-day repeated-dose liver micronucleus assay using male young adult rats.
Kawasako, K; Matsumoto, H; Sui, H; Wako, Y, 2015
)
0.69
" Finally, after treatment with L-buthionine-S,R-sulfoxinine, an inhibitor of glutathione synthesis, TA-induced hepatic necrosis was enhanced and hepatic TBARS contents increased after TA dosing in HFD mice."( Hepatic glutathione contributes to attenuation of thioacetamide-induced hepatic necrosis due to suppression of oxidative stress in diet-induced obese mice.
Kai, K; Makino, T; Matsuoka, M; Shirai, M; Takasaki, W; Teranishi, M, 2015
)
0.67
" Western blot analysis revealed that hepatic phosphorylated p38 MAPK protein decreased at 8 and 24 hours (hr) after TA dosing in the HFD mice, while it decreased only at 24 hr in the ND mice in comparison to the time- and diet-matched, vehicle-treated mice."( Decreased hepatic phosphorylated p38 mitogen-activated protein kinase contributes to attenuation of thioacetamide-induced hepatic necrosis in diet-induced obese mice.
Arakawa, S; Kai, K; Shirai, M; Teranishi, M, 2016
)
0.65
"Thirty-six albino rats were divided into six groups: Control group; TAA group (IP injection with TAA at a dosage of 200 mg/Kg three times a week for two months); TAA + NA group (rats administered with NA at a dosage of 200 mg/kg daily besides TAA as in the control); TAA + VB2 group (rats administered with vitamin B2 at a dosage of 30 mg/kg daily besides injection with TAA); TAA + VC group (rats administered with vitamin C at a dosage of 200 mg/kg daily along with injection of TAA)."( Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide.
Abdelmottaleb Moussa, SA; Al Tamimi, J; Alaamer, A; Alhazza, IM; Bashandy, SAE; Ebaid, H; Hassan, I, 2018
)
0.69
" Oral dosing of perindopril for 4 weeks concomitant with TAA could mend the altered parameters near to normal values and abolished the ongoing fibrosis extension."( Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat.
Abd El-Rahman, SS; Fayed, HM, 2019
)
0.51
" The acceleration of liver fibrosis can occur with prolonged administration as well as the high dosage of hepatotoxins in mice."( Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice.
George Thomas, R; Jeong, YY; Kim, DH; Kim, KH; Moon, MJ; Park, R; Poilil Surendran, S, 2020
)
0.56
" The metformin-treated group received 200 mg/kg metformin daily for 10 weeks, beginning week 1, and received TAA injections with dosage and timing similar to those of the model group."( Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension.
Al-Ani, B; Albawardi, A; Alqahtani, SM; Alshahrani, MY; Bayoumy, NM; Ebrahim, HA; Haidara, MA; Kamar, SS; ShamsEldeen, AM, 2023
)
1.23
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
hepatotoxic agentA role played by a chemical compound exihibiting itself through the ability to induce damage to the liver in animals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
thiocarboxamideAny primary amide having its amide oxygen replaced by sulfur.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency43.64120.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)Activity100.00000.15003.256310.0000AID1619467
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
detection of chemical stimulus involved in sensory perception of bitter tasteTaste receptor type 2 member 38Homo sapiens (human)
G protein-coupled receptor signaling pathwayTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityTaste receptor type 2 member 38Homo sapiens (human)
bitter taste receptor activityTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID588208Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset2010Molecular pharmaceutics, Oct-04, Volume: 7, Issue:5
Predicting phospholipidosis using machine learning.
AID540235Phospholipidosis-negative literature compound
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,642)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990433 (26.37)18.7374
1990's206 (12.55)18.2507
2000's310 (18.88)29.6817
2010's487 (29.66)24.3611
2020's206 (12.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.75 (24.57)
Research Supply Index7.44 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index95.03 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (0.23%)5.53%
Reviews15 (0.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other1,686 (98.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]